E7090
E7090-J000-201
Phase 2 small_molecule completed
Quick answer
E7090 for Cholangiocarcinoma is a Phase 2 program (small_molecule) at Eisai Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eisai Co.,
- Indication
- Cholangiocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed